Elucidating how metabolic sensors, such as HIF-1α, GLUT1, SIRT1, and AMPK, influence NK cell function in COVID-19 will enhance our understanding of disease pathogenesis and serve as a basis for novel therapeutic approaches in patients with COVID-19. This evidence concerns the gene HIF1A and COVID-19.